NEW YORK (Thomson Financial) - PDI Inc. Friday said it has signed a
four-year agreement with Novartis AG to promote one of the drugmaker's products
in the U.S.
The product was not named and financial terms weren't disclosed.
PDI intends to deploy about 100 full-time sales representatives nationwide
to call on physicians, and said it expects the deal to be dilutive to earnings
in 2008 but add to earnings beginning in 2009.
PDI shares closed at $8.71 on Thursday. Novartis shares closed at $9.58.
Christie Rizk
cr/pc
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|